TYRA
Tyra Biosciences, Inc.
Next earnings Aug 12, 2026 · consensus $-0.66 EPS
Last earnings +3.8% on 2026-05-13
$30.94▲ +235.21%
over 1Y
L $9.10EODHDH $39.61
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W+9.3%
1M-7.9%
3M-18.6%
YTD+15.5%
1Y+235.2%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 21 analysts
Strong Buy
Conservative balance sheet (liabilities/equity 0.09x).
Tyra Biosciences, Inc. shows limited reported revenue, and -46.3% ROE.
Sources: SEC EDGAR (CIK 0001863127, latest 10-Q filed 2026-05-13) · as of 6/26/2026, 2:18:13 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.